Sodium Acetate
NDC 0641-6262, Sodium Acetate, injection, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0641-6262
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216920
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6262 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM ACETATE ANHYDROUS164 mg/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0641-6262-01 | 00641626201 | 1 VIAL in 1 CARTON (0641-6262-01) / 50 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7ee23a1c-bc99-4ff6-b2e7-d2aa42744553
Use it
Look up 0641-6262 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6262 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0641-6262. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.